AbsciABSI
About: Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.
Employees: 156
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
526% more call options, than puts
Call options by funds: $2.77M | Put options by funds: $442K
82% more repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 22
6.27% more ownership
Funds ownership: 53.75% [Q1] → 60.02% (+6.27%) [Q2]
9% less first-time investments, than exits
New positions opened: 30 | Existing positions closed: 33
3% less funds holding
Funds holding: 113 [Q1] → 110 (-3) [Q2]
39% less capital invested
Capital invested by funds: $344M [Q1] → $209M (-$135M) [Q2]
Research analyst outlook
2 Wall Street Analysts provided 1 year price targets over the past 3 months
2 analyst ratings
Guggenheim Vamil Divan 67% 1-year accuracy 10 / 15 met price target | 146%upside $10 | Buy Initiated | 2 Oct 2024 |
HC Wainwright & Co. Swayampakula Ramakanth 24% 1-year accuracy 33 / 138 met price target | 72%upside $7 | Buy Reiterated | 15 Aug 2024 |